Bulters, Mr Diederik
Training and education
MBChB and intercalated BSc in pharmacology, concentrating on neurophysiology, University of Edinburgh
Basic surgical training, University of Edinburgh
Specialist neurosurgical training, Wessex
- Fellowship in neurovascular surgery, Cambridge
Mr Bulters is a consultant neurosurgeon specialising in neurovascular neurosurgery (treating conditions of the blood vessels in the brain and spine).
After completing his fellowship in Cambridge, he worked as a consultant neurosurgeon at Addenbrooke’s Hospital before moving back to Southampton. He has extensive experience in complex surgery for:
- aneurysms (swelling in a blood vessel caused by weakness in the blood vessel wall)
- arteriovenous malformations (groups of blood vessels that form abnormally)
- dural arteriovenous fistulas (abnormal connections between an artery and a vein in part of the brain and spine called the dura mater).
Mr Bulters also provides all services for cerebral bypass (an operation to reroute blood around a damaged artery, preventing a stroke) in the south.
- President of the British Neurovascular Group
- Member of the Society of British Neurological Surgeons, European Association of Neurosurgical Societies and the Congress of Neurological Surgeons
- Teaches and lectures on a wide range of courses nationally and internationally
- Society of British Neurological Surgeons Research Committee member and associate editor of the British Journal of Neurosurgery
Mr Bulters has an active research interest in vascular neurosurgery and holds grants from the NIHR, EPSRC, Innovate UK, MRC, European Union, Royal College of Surgeons of Edinburgh, Wessex Medical Research and Smile for Wessex.
Mr Bulters has been the chief and principal investigator for a large portfolio of randomised trials examining new ways to improve outcomes following intracranial haemorrhage and head injury, utilising new drug interventions and surgical techniques. He also has a particular research interest in risk prediction for patients with cerebral aneurysms, arteriovenous malformations and dural AV fistulae.
He is also an honorary clinical lecturer at the University of Southampton, specialising in the translation of laboratory studies into clinical intervention. At the university he works closely with the team to investigate the biochemical effects of haemorrhage on the brain, and how these may be manipulated and ameliorated. This has led to a number of exciting putative interventions that are proceeding into human clinical trials.